The announcement of an interim independent analysis for a significant study like Alzheimer's could potentially influence investor sentiment towards Annovis Bio. If the analysis shows promising results, it could boost the company's stock. However, if the results are not as expected, it could negatively impact the stock. At this point, the impact is neutral until the results of the analysis are known.